Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating Envafolimab in combination with chemotherapy as neoadjuvant therapy for resectable esophageal squamous c…
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Efficacy and Safety of Tislelizumab and Nab-paclitaxel Combined With Low-dose Radiotherapy in Patients With Stage IVb Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 study assessing the efficacy and safety of tislelizumab plus nab-paclitaxel with low-dose radiotherapy in stage IVb esophageal squ…
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC [Phase 1, Phase 2]
Phase 1/2 trial evaluating pembrolizumab with chemoradiotherapy followed by surgery for esophageal squamous cell carcinoma; status currently…
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC [Phase 2]
Phase 2 trial exploring AK104 alone or with chemotherapy as first-line treatment for esophageal squamous cell carcinoma (ESCC). Status and r…
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC [Phase 2]
Phase II clinical study evaluating HLX07 combination therapy or HLX07 monotherapy in advanced esophageal squamous cell carcinoma or esophage…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel [Phase 2]
A Phase 2 clinical trial is underway to evaluate the safety and efficacy of a chemotherapy regimen (5-FU, oxaliplatin, and docetaxel) for es…
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: Trastuzumab and Standard Treatment With Chemo- and Immunotherapy as First Line Treatment for HER2 Positive Esophageal Squamous Cell Carcinoma Patients [Phase 2]
Phase 2 trial evaluating trastuzumab with chemo- and immunotherapy as first-line treatment for HER2-positive esophageal squamous cell carcin…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903) [Phase 3]
Phase 3 trial comparing neoadjuvant chemotherapy to neoadjuvant chemoradiotherapy for resectable locally advanced esophageal cancer (Esophag…
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial update for KN046 in late-stage esophageal squamous cell carcinoma has completed enrollment and results are likely t…
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update of camrelizumab plus chemotherapy as neoadjuvant therapy for resectable locally advanced esophageal squamous cell carci…
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC [Phase 2]
Phase 2 trial evaluating tislelizumab with chemotherapy for conversion therapy in locally nonresectable esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer [Phase 2]
Phase 2 trial update evaluating sintilimab plus chemotherapy as neoadjuvant treatment for potentially resectable esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial updating the use of tislelizumab in combination with chemotherapy for unresectable esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab combined with palliative radiation therapy in patients with metastatic cancers of the esophagus, st…
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC [Phase 2, Phase 3]
A phase 2/3 clinical trial is evaluating neoadjuvant immunotherapy plus chemoradiation versus neoadjuvant chemoradiation for locally advance…
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus [Phase 2]
Phase 2 trial evaluating short-course neoadjuvant chemo-radiotherapy plus toripalimab for locoregionally advanced resectable esophageal squa…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC [Phase 2, Phase 3]
Clinical trial update for neoadjuvant nivolumab or placebo plus chemotherapy followed by surgery and adjuvant treatment in resectable esopha…
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma [Phase 2]
Phase 2 trial update evaluating neoadjuvant SHR-1316 immunoreagent for resectable esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC [Phase 2, Phase 3]
A phase 2/3 trial comparing paclitaxel/cisplatin versus cisplatin/5-fluorouracil in neoadjuvant chemoradiation for esophageal squamous cell …
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002) [Phase 3]
Phase 3 trial comparing pembrolizumab plus neoadjuvant chemotherapy to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous…
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC [Phase 1, Phase 2]
Phase 1/2 trial evaluating chemoradiation plus tislelizumab for conversion therapy in locally nonresectable esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Esophageal Arterial Infusion Chemotherapy Versus Systemic Intravenous Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Prospective, Multicentre, Randomised Controlled Clinical Study [Phase 2]
A Phase 2 randomized trial comparing esophageal arterial infusion chemotherapy to systemic intravenous chemotherapy in resectable locally ad…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma. [Phase 1, Phase 2]
A clinical trial update for an anti-PD-L1 antibody combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma (Phase 1/Pha…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer [Phase 2]
Phase II trial update evaluating camrelizumab with chemotherapy or anlotinib in advanced esophageal squamous cell carcinoma (Stage IV).
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating nivolumab as immune checkpoint therapy for esophageal squamous cell carcinoma; the study status is terminated w…